Ruxolitinib (Jakafi)


Indications

Alopecia Areata (see xxxx)

Myelofibrosis (see Primary Myelofibrosis)

Polycythemia Vera (see Polycythemia Vera)

Psoriasis (see Psoriasis)

Rheumatoid Arthritis (RA) (see Rheumatoid Arthritis)

Chronic Graft vs Host Disease (GVHD) (see Graft vs Host Disease)


Pharmacology

Metabolism


Administration

Dose Adjustment


Adverse Effects

Hematologic Adverse Effects

Infectioius Adverse Effects

Pulmonary Adverse Effects

Other Adverse Effects


References